SGLT2 Diabetes Drugs Show Surprising Arthritis Benefit
A large Korean study finds fewer autoimmune arthritis cases among SGLT2 inhibitor users compared with sulfonylureas
In a nationwide Korean study of over two million adults with type 2 diabetes, patients who started on SGLT2 inhibitors had a modestly lower risk of developing autoimmune rheumatic diseases especially inflammatory arthritis compared with those taking sulfonylureas.
Study Details:
Researchers from Sungkyunkwan University in Seoul analyzed data from South Ko…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.